A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (= 16 years) low grade glioma - A final report (vol 81, pg 206, 2017)

Gnekow Astrid K.; Walker David A.; Kandels Daniela; Picton Susan; Perilongo Giorgio; Grill Jacques; Stokland Tore; Sandstrom Per Eric; Warmuth-Metz Monika; Pietsch Torsten; Giangaspero Felice; Schmidt Rene; Faldum Andreas; Kilmartin Denise; De Paoli Angela; De Salvo Gian Luca

首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (= 16 years) low grade glioma - A final report (vol 81, pg 206, 2017)

【24h】

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (= 16 years) low grade glioma - A final report (vol 81, pg 206, 2017)

机译：欧洲随机对照试验，将依托泊苷添加到标准的长春新碱和卡铂诱导，作为儿童（＆ = 16岁）的18个月治疗方案的一部分（＆ = 16岁）低级胶质瘤 - 最终报告（第81卷，PG 206,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)》 |2018年第2018期|共2页
作者
Gnekow Astrid K.; Walker David A.; Kandels Daniela; Picton Susan; Perilongo Giorgio; Grill Jacques; Stokland Tore; Sandstrom Per Eric; Warmuth-Metz Monika; Pietsch Torsten; Giangaspero Felice; Schmidt Rene; Faldum Andreas; Kilmartin Denise; De Paoli Angela; De Salvo Gian Luca;
展开▼
作者单位

Klinikum Augsburg Swabian Childrens Canc Ctr Augsburg Germany;

Univ Nottingham Childrens Brain Tumour Res Ctr Nottingham NG7 2UH England;

Univ Nottingham Childrens Brain Tumour Res Ctr Nottingham NG7 2UH England;

Leeds Childrens Hosp Leeds W Yorkshire England;

Univ Hosp Padua Div Pediat Padua Italy;

Inst Gustave Roussy Paris France;

Univ Hosp North Norway Tromso Norway;

Umea Univ Umea Sweden;

Univ Wurzberg Dept Neuroradiol Wurzburg Germany;

Univ Bonn Med Ctr Bonn Germany;

Univ Rome Sapienza Rome Italy;

Univ Munster Inst Biostat &

Clin Res Munster Germany;

Univ Munster Inst Biostat &

Clin Res Munster Germany;

IRCCS Ist Oncol Veneto Clin Trials &

Biostat Unit Padua Italy;

IRCCS Ist Oncol Veneto Clin Trials &

Biostat Unit Padua Italy;

IRCCS Ist Oncol Veneto Clin Trials &

Biostat Unit Padua Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献

1. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (= 16 years) low grade glioma - A final report (vol 81, pg 206, 2017) [J] . Gnekow Astrid K., Walker David A., Kandels Daniela, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：欧洲随机对照试验，将依托泊苷添加到标准的长春新碱和卡铂诱导，作为儿童（＆ = 16岁）的18个月治疗方案的一部分（＆ = 16岁）低级胶质瘤 - 最终报告（第81卷，PG 206,2017）
2. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604) [J] . Cafferty Fay H., White Jeff D., Shamash Jonathan, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2020,第期

机译：具有强化诱导化疗的长期成果（卡铂，博尔霉素，长霉素和顺铂，依托磷脂和顺铂）和标准博来霉素，依托磷脂在预后差异细胞肿瘤中的标准博霉素：随机期II试验（ISRCTN53643604）
3. Early Versus Delayed Endocrine Treatment of T2-T3 pNl-3 MO Prostate Cancer Without Local Treatment of the Primary Tumour: Final Results of European Organisation for the Research and Treatment of Cancer Protocol 30846 After 13 Years of Follow-up (A Randomised Controlled Trial) [J] . Fritz H. Schroder Karl Heinz Kurth, Sophie D. Fossa, Wytse Hoekstra, European urology . 2009,第1期

机译：没有对原发性肿瘤进行局部治疗的T2-T3 pNl-3 MO前列腺癌的早期与延迟内分泌治疗：经过13年的随访，欧洲研究和治疗癌症方案组织30846的最终结果（随机对照试验）
4. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report [O] . Astrid K. Gnekow, David A. Walker, Daniela Kandels, -1

机译：一项欧洲随机对照试验在标准的长春新碱和卡铂诱导中添加依托泊苷作为儿童（≤16岁）低度神经胶质瘤的18个月治疗方案的一部分–最终报告
5. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (<= 16 years) low grade glioma - A final report [O] . Gnekow, Astrid K., Walker, David A., Kandels, Daniela, 2017

机译：欧洲一项随机对照试验，在标准的长春新碱和卡铂诱导中添加依托泊苷，作为儿童（<= 16岁）低度胶质瘤的18个月治疗方案的一部分-最终报告

A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (= 16 years) low grade glioma - A final report (vol 81, pg 206, 2017)

著录项

相似文献

相关主题

期刊订阅